查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934262

基因克隆服務市場－全球產業規模、佔有率、趨勢、機會及預測（按服務類型、基因類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

Gene Cloning Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service Type, By Gene Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球基因克隆服務市場預計將從 2025 年的 35.9 億美元成長到 2031 年的 85.4 億美元，複合年成長率達 15.54%。

這些服務包括用於組裝重組DNA分子並在宿主生物體中複製以創建相同基因拷貝的專業實驗室技術，涵蓋誘變、質體設計、基因合成等關鍵過程。該市場的主要成長要素是生物技術產業的快速發展，尤其是在生物製藥開發領域；對個人化醫療的需求不斷成長；以及為應對慢性病和遺傳疾病日益增多而加快研究工作流程的必要性。

市場概覽
預測期 2027-2031
市場規模：2025年 35.9億美元
市場規模：2031年 85.4億美元
複合年成長率：2026-2031年 15.54%
成長最快的細分市場 基因合成
最大的市場 北美洲

然而，由於先進克隆技術營運成本高且技術複雜，市場面臨許多挑戰，這為小規模研究機構進入該領域設置了准入門檻。儘管存在這些挑戰，但行業趨勢表明，對這些服務的需求仍然至關重要。根據美國基因與細胞治療學會 (ASGCT) 預測，到 2025 年，全球將進行超過 3,200 項基因、細胞和 RNA 療法的臨床試驗，凸顯了克隆服務在維持這龐大的治療開發平臺中所發揮的關鍵作用。

市場促進因素

基因和細胞療法需求的激增是全球基因克隆服務市場的主要驅動力。隨著製藥研發管線向生物製藥領域集中，對精準克隆的需求日益成長，以生產用於腫瘤和罕見遺傳疾病治療的病毒載體、重組質體和修飾DNA序列。監管政策的發展進一步推動了這項需求。根據再生醫學聯盟2024年1月發布的《產業趨勢》報告，2023年美國和歐盟將核准創紀錄的五種罕見疾病基因療法。這表明該市場日趨成熟，並將高度依賴可擴展的克隆工作流程。

此外，政府和私人對生命科學領域的投入增加，正在加速克隆操作外包模式的轉變。這種財政支持使得學術機構和生物技術公司能夠利用專業服務提供者，而無需投資建設資本密集的內部設施。研發投入的大幅成長也支撐了這個趨勢。根據美國藥品研究與製造商協會（PhRMA）於2024年8月發布的《2024年會員調查報告》，預計會員公司在2023年的研發投入將達到1,035億美元。這種強勁的資金環境直接惠及服務供應商，Twist Bioscience於2024年11月發布的2024年財務報告顯示，其總收入為3.13億美元，反映出該公司對合成生物學和克隆服務的依賴程度日益加深。

市場挑戰

先進基因克隆技術的複雜性和高昂的營運成本嚴重限制了全球基因克隆服務市場的成長。這些複雜的技術需要昂貴的設備、專用試劑和高技能人員，給新興生物技術公司和小規模研究機構帶來了巨大的經濟負擔。因此，這些代理商往往難以獲得足夠的預算來外包關鍵服務，從而限制了其潛在基本客群，並減緩了精準克隆技術的廣泛應用。

由於近期該產業核心客戶群可獲得的投資資本減少，這項財務負擔進一步加劇。根據生技創新組織（BIO）預測，生技Start-Ups公司的資金籌措預計將在2025年大幅下降，從第一季的26億美元降至第二季的9億美元。融資金額的顯著下降迫使早期公司縮減研發活動，從而降低了對外部基因克隆服務的需求，並阻礙了市場的快速擴張潛力。

市場趨勢

人工智慧（AI）輔助序列最佳化技術的整合正在透過改進複雜基因構建體的預測設計，變革基因克隆領域。利用先進的演算法進行大規模數據分析，供應商能夠在合成前最佳化密碼子使用、預測二級結構並識別不穩定區域，從而降低失敗率並加快從設計到上市的時間。這項技術的影響深遠：根據皮斯托亞聯盟於2025年9月發布的《未來實驗室2025調查報告》，77%的生命科學實驗室計畫在未來兩年內實施人工智慧技術，這標誌著基因工程領域正向計算精度方向發生重大轉變。

同時，自動化高通量克隆平台的引入，透過實現大規模文庫的快速處理，正在徹底改變克隆規模。透過以機器人液體處理系統取代人工移液，服務供應商可以同時進行數千個克隆反應，顯著縮短突變體文庫建構和大規模質體製備的周轉時間。這些營運效率的提升正在推動商業性成長。金斯瑞生技股份有限公司於2025年3月發布的「2024會計年度財務表現」預測，持續經營業務的營收將達到5.945億美元，這印證了該公司在支持其向工業規模克隆擴張方面取得的財務成功。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球基因克隆服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依服務類型（基因合成服務、分子生物學服務、客製化克隆服務、其他）
    • 依基因類型（單鏈基因、複雜基因等）
    • 依應用領域（基因合成、基因表現、基因治療、疫苗研究等）
    • 依最終用戶（製藥/生技公司、臨床試驗機構等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美基因克隆服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲基因克隆服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區基因克隆服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲基因克隆服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲基因克隆服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球基因克隆服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific, Inc
  • Eurofins Scientific SE
  • GenScript Biotech Corp
  • Merck KGaA
  • Takara Bio Inc
  • Charles River Laboratories International, Inc
  • Sartorius AG
  • Cellecta, Inc
  • Creative Biogene, Inc
  • Biocompare, Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 11781

The Global Gene Cloning Services Market is projected to expand from USD 3.59 Billion in 2025 to USD 8.54 Billion by 2031, registering a CAGR of 15.54%. These services involve specialized laboratory techniques designed to assemble recombinant DNA molecules and replicate them within host organisms to create identical genetic copies, encompassing essential processes such as mutagenesis, plasmid design, and gene synthesis. The market is primarily driven by the booming biotechnology sector, particularly in biologics development, and the increasing demand for personalized medicine, alongside the need to accelerate research workflows to address the rising prevalence of chronic and genetic diseases.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.59 Billion
Market Size 2031USD 8.54 Billion
CAGR 2026-203115.54%
Fastest Growing SegmentGene Synthesis
Largest MarketNorth America

However, the market faces obstacles due to the high operational costs and technical complexities of advanced cloning procedures, which create entry barriers for smaller research entities. Despite these challenges, the necessity for these services remains critical, as reflected in industry activity. According to the American Society of Gene & Cell Therapy, over 3,200 gene, cell, and RNA therapy trials were active globally in 2025, highlighting the indispensable role of cloning services in sustaining this extensive pipeline of therapeutic developments.

Market Driver

The surging demand for gene and cell therapies acts as a major catalyst for the Global Gene Cloning Services Market. As pharmaceutical pipelines increasingly focus on biologics, the need for precision cloning to produce viral vectors, recombinant plasmids, and modified DNA sequences for treating oncology and rare genetic disorders has intensified. This demand is further supported by regulatory achievements; according to the Alliance for Regenerative Medicine's January 2024 "State of the Industry" report, a record five gene therapies for rare diseases received approval in the United States and European Union in 2023, indicating a maturing market that depends heavily on scalable cloning workflows.

Additionally, rising government funding and private investment in life sciences are accelerating the shift toward outsourced cloning models. This financial support enables academic centers and biotech firms to utilize specialized providers rather than investing in capital-intensive in-house facilities. This trend is underscored by substantial R&D spending; PhRMA's "2024 Membership Survey" from August 2024 notes that member companies invested USD 103.5 billion in research and development in 2023. This robust funding environment directly benefits service providers, as evidenced by Twist Bioscience's "Fiscal 2024 Financial Results" in November 2024, which reported USD 313 million in total revenue, reflecting the growing reliance on synthetic biology and cloning services.

Market Challenge

The substantial technical complexity and high operational costs associated with advanced gene cloning procedures present a significant barrier to the growth of the Global Gene Cloning Services Market. These intricate techniques require expensive instrumentation, specialized reagents, and highly skilled personnel, establishing steep financial hurdles for emerging biotechnology firms and smaller research institutions. Consequently, these entities often struggle to allocate sufficient budgets for outsourcing critical services, which limits the potential customer base and slows the broader adoption of precision cloning technologies.

This financial strain is further highlighted by recent declines in investment capital available to the sector's core clientele. According to the Biotechnology Innovation Organization, biotech startup funding dropped sharply in 2025, falling from 2.6 billion dollars in the first quarter to 900 million dollars in the second quarter. This significant reduction in capital forces early-stage companies to scale back their research and development activities, thereby diminishing the demand for external gene cloning services and impeding the market's potential for rapid expansion.

Market Trends

The integration of Artificial Intelligence for Sequence Optimization is transforming the gene cloning landscape by improving the predictive design of complex genetic constructs. Advanced algorithms are increasingly utilized to analyze large datasets, allowing providers to optimize codon usage, predict secondary structures, and identify instability regions prior to synthesis, thus reducing failure rates and accelerating the design-to-product timeline. The impact of this technology is significant; according to the Pistoia Alliance's "2025 Lab of the Future Survey" released in September 2025, 77% of life sciences laboratories plan to adopt AI technologies within the next two years, signaling a major shift toward computational precision in genetic engineering.

Simultaneously, the deployment of Automated High-Throughput Cloning Platforms is revolutionizing scalability by enabling the rapid processing of massive libraries. By replacing manual pipetting with robotic liquid handling systems, service providers can execute thousands of cloning reactions concurrently, drastically reducing turnaround times for mutant library construction and large-scale plasmid preparation. This operational efficiency is driving commercial growth, as illustrated by GenScript Biotech Corporation's "FY 2024 Results" in March 2025, which reported continuing operations revenue of USD 594.5 million, underscoring the financial success supporting their industrial-scale cloning expansion.

Key Market Players

  • Thermo Fisher Scientific, Inc
  • Eurofins Scientific SE
  • GenScript Biotech Corp
  • Merck KGaA
  • Takara Bio Inc
  • Charles River Laboratories International, Inc
  • Sartorius AG
  • Cellecta, Inc
  • Creative Biogene, Inc
  • Biocompare, Inc

Report Scope

In this report, the Global Gene Cloning Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Cloning Services Market, By Service Type

  • Gene Synthesis Service
  • Molecular Biology Service
  • Custom Cloning Service
  • Others

Gene Cloning Services Market, By Gene Type

  • Stranded Gene
  • Complex Gene
  • Others

Gene Cloning Services Market, By Application

  • Gene Synthesis
  • Gene Expression
  • Gene Therapy
  • Vaccine Research
  • Others

Gene Cloning Services Market, By End User

  • Pharmaceutical & Biotechnology Companies
  • Clinical Laboratories
  • Others

Gene Cloning Services Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gene Cloning Services Market.

Available Customizations:

Global Gene Cloning Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Cloning Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service Type (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, Others)
    • 5.2.2. By Gene Type (Stranded Gene, Complex Gene, Others)
    • 5.2.3. By Application (Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, Others)
    • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Gene Cloning Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service Type
    • 6.2.2. By Gene Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gene Cloning Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service Type
        • 6.3.1.2.2. By Gene Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Gene Cloning Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service Type
        • 6.3.2.2.2. By Gene Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Gene Cloning Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service Type
        • 6.3.3.2.2. By Gene Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Gene Cloning Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service Type
    • 7.2.2. By Gene Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Gene Cloning Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service Type
        • 7.3.1.2.2. By Gene Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Gene Cloning Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service Type
        • 7.3.2.2.2. By Gene Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Gene Cloning Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service Type
        • 7.3.3.2.2. By Gene Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Gene Cloning Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service Type
        • 7.3.4.2.2. By Gene Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Gene Cloning Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service Type
        • 7.3.5.2.2. By Gene Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Gene Cloning Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service Type
    • 8.2.2. By Gene Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Gene Cloning Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service Type
        • 8.3.1.2.2. By Gene Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Gene Cloning Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service Type
        • 8.3.2.2.2. By Gene Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Gene Cloning Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service Type
        • 8.3.3.2.2. By Gene Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Gene Cloning Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service Type
        • 8.3.4.2.2. By Gene Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Gene Cloning Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service Type
        • 8.3.5.2.2. By Gene Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Gene Cloning Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service Type
    • 9.2.2. By Gene Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Gene Cloning Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service Type
        • 9.3.1.2.2. By Gene Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Gene Cloning Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service Type
        • 9.3.2.2.2. By Gene Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Gene Cloning Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service Type
        • 9.3.3.2.2. By Gene Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Gene Cloning Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service Type
    • 10.2.2. By Gene Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gene Cloning Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service Type
        • 10.3.1.2.2. By Gene Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Gene Cloning Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service Type
        • 10.3.2.2.2. By Gene Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Gene Cloning Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service Type
        • 10.3.3.2.2. By Gene Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Gene Cloning Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Eurofins Scientific SE
  • 15.3. GenScript Biotech Corp
  • 15.4. Merck KGaA
  • 15.5. Takara Bio Inc
  • 15.6. Charles River Laboratories International, Inc
  • 15.7. Sartorius AG
  • 15.8. Cellecta, Inc
  • 15.9. Creative Biogene, Inc
  • 15.10. Biocompare, Inc

16. Strategic Recommendations

17. About Us & Disclaimer